ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 731

Performance of the Old ACR and the New ACR-EULAR Systemic Sclerosis Classification Criteria in Patients with Limited Cutaneous Disease: Effect on the Ascertainment of Severe Pulmonary Arterial Hypertension

Beatriz E. Joven1, M Jesus Garcia de Yebenes2, Pilar Escribano3,4, Estibaliz Loza2,5, M Jose Ruiz-Cano4, Carmen Jimenez Lopez-Guarch4, Loreto Carmona6 and Patricia E. Carreira1, 1Rheumatology Department. Hospital Universitario 12 de Octubre, Madrid, Spain, 2Instituto de Salud Musculoesqueletica, Madrid, Spain, 3Multidisciplanry Pulmonary Hypertension Unit. Hospital Universitario 12 de Octubre, Madrid, Spain, 4Multidisciplinary Pulmonary Hypertension Unit. Hospital Universitario 12 de Octubre, Madrid, Spain, 5Institu, Madrid, Spain, 6Instituto de Salud Musculoesquelética, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: classification criteria, Pulmonary complications and scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis Measures and Outcomes

Session Type: Abstract Submissions (ACR)

Background/Purpose To analyze the performance of the old ACR1980 and the new ACR-EULAR2013 classification criteria for systemic sclerosis (SSc) in patients with limited disease in clinical practice, and to compare the characteristics of patients with severe pulmonary arterial hypertension (PAH) who fulfilled or did not fulfill the 1980 criteria

Methods All patients with clinical diagnosis of limited cutaneous SSc followed in a single center from Jan1990 to May2014 were included. Descriptive analysis and comparisons between groups, according to their performance in new and old criteria, were carried out by parametric or non parametric tests based on the distribution of the variables

Results

From 321 patients, 202 (63%) fulfilled the 1980 and 297 (93%) fulfilled the 2013 criteria. Compared to those fulfilling 2013 criteria only, patients fulfilling 1980 criteria also were younger at diagnosis (48 vs 52 y), presented higher mRSS (8.5 vs 2.7) and had significantly more aScl70, esophagic involvement, lung fibrosis, ischaemic lesions, calcinosis and telangiectasia. In contrast, patients not fulfilling 1980 criteria had more ACA (61 vs 44%) and severe PAH (17 vs 9%) (Table 1).

Within the group of patients with severe PAH (n=38), all fulfilled the 2013 but only 18 (47%) fulfilled the 1980 criteria. Clinical characteristics between those who fulfilled and did not fulfill 1980 criteria were similar, except for higher frequency of calcinosis (85 vs 22%) and ischaemic lesions (83% vs 0%) in the former group. In hemodynamics, patients not fulfilling 1980 criteria had higher pulmonary vascular resistance (16 vs 7) and lower cardiac index (2.2 vs 3.2). Mortality was high in both groups (72 vs 65%)(Table 2)

Conclusion The new SSc ACR-EULAR2013 criteria perform better than the old ACR1980 criteria in clinical practice. Patients with mild symptoms, not fulfilling 1980 criteria, are at higher risk of developing severe PAH, with increased mortality. Our study points out: 1) the need to apply the new criteria to all patients with SSc suspicion; and 2) since SSc-PAH has better prognosis if treated early, all SSc patients, even with very mild disease, should be screened to diagnose PAH as early as possible


Disclosure:

B. E. Joven,
None;

M. J. Garcia de Yebenes,
None;

P. Escribano,
None;

E. Loza,
None;

M. J. Ruiz-Cano,
None;

C. Jimenez Lopez-Guarch,
None;

L. Carmona,
None;

P. E. Carreira,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-the-old-acr-and-the-new-acr-eular-systemic-sclerosis-classification-criteria-in-patients-with-limited-cutaneous-disease-effect-on-the-ascertainment-of-severe-pulmonary-arterial-hyperte/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology